Aktiesnakken — Januar 2011
-
hvad med al dit fucom cash
-
Genmab er ikke valueret til meget andet end kassebeholdning
-
så der kan være en del upside i nogle nyheder i den være det sig fabrik, zalutumumab eller salgstal
-
bavarian er jo steget en del, men det er et spændende firma
-
er du vimmer en forventning fantomas!
-
vestas er også en mulighed, men jeg er sjældent så kort
-
vi har jo været før med funcom
-
mornings
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind